Literature DB >> 33272979

Targeting G protein-coupled receptors for the treatment of chronic pain in the digestive system.

Lena Gottesman-Katz1,2, Rocco Latorre1, Stephen Vanner3, Brian L Schmidt4, Nigel W Bunnett5.   

Abstract

Chronic pain is a hallmark of functional disorders, inflammatory diseases and cancer of the digestive system. The mechanisms that initiate and sustain chronic pain are incompletely understood, and available therapies are inadequate. This review highlights recent advances in the structure and function of pronociceptive and antinociceptive G protein-coupled receptors (GPCRs) that provide insights into the mechanisms and treatment of chronic pain. This knowledge, derived from studies of somatic pain, can guide research into visceral pain. Mediators from injured tissues transiently activate GPCRs at the plasma membrane of neurons, leading to sensitisation of ion channels and acute hyperexcitability and nociception. Sustained agonist release evokes GPCR redistribution to endosomes, where persistent signalling regulates activity of channels and genes that control chronic hyperexcitability and nociception. Endosomally targeted GPCR antagonists provide superior pain relief in preclinical models. Biased agonists stabilise GPCR conformations that favour signalling of beneficial actions at the expense of detrimental side effects. Biased agonists of µ-opioid receptors (MOPrs) can provide analgesia without addiction, respiratory depression and constipation. Opioids that preferentially bind to MOPrs in the acidic microenvironment of diseased tissues produce analgesia without side effects. Allosteric modulators of GPCRs fine-tune actions of endogenous ligands, offering the prospect of refined pain control. GPCR dimers might function as distinct therapeutic targets for nociception. The discovery that GPCRs that control itch also mediate irritant sensation in the colon has revealed new targets. A deeper understanding of GPCR structure and function in different microenvironments offers the potential of developing superior treatments for GI pain. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  abdominal pain; cell signalling; neurobiology; neurogastroenterology; receptor characterisation

Mesh:

Substances:

Year:  2020        PMID: 33272979     DOI: 10.1136/gutjnl-2020-321193

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   31.793


  7 in total

1.  Predictive Factors for Acute Postoperative Pain After Open Radical Gastrectomy for Gastric Cancer.

Authors:  Han Xie; Jingxuan Wei; Zhengliang Ma; Weihong Ge
Journal:  Front Public Health       Date:  2022-06-01

2.  GPCR Intracellular Loop Regulation of Beta-Arrestin-Mediated Endosomal Signaling Dynamics.

Authors:  Jianing Li; Jacob M Remington; Chenyi Liao; Rodney L Parsons; Severin Schneebeli; Karen M Braas; Victor May; Matthias Brewer
Journal:  J Mol Neurosci       Date:  2022-05-10       Impact factor: 2.866

Review 3.  Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS.

Authors:  Lisse Decraecker; Guy Boeckxstaens; Alexandre Denadai-Souza
Journal:  Front Physiol       Date:  2022-05-19       Impact factor: 4.755

Review 4.  New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.

Authors:  Michael Camilleri
Journal:  Gastroenterology       Date:  2021-05-11       Impact factor: 33.883

5.  GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, But Not Female Mice.

Authors:  Akila Ram; Taylor Edwards; Ashley McCarty; Leela Afrose; Max V McDermott; Erin N Bobeck
Journal:  Front Pain Res (Lausanne)       Date:  2021-09-10

6.  GPCR genes as a predictor of glioma severity and clinical outcome.

Authors:  Eun-A Ko; Tong Zhou
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

7.  RNA sequencing profiling of mRNAs, long noncoding RNAs, and circular RNAs in Trigeminal Ganglion following Temporomandibular Joint inflammation.

Authors:  Xiaojun Liu; Chenchen Zhao; Yupeng Han; Ruixia Feng; Xiaona Cui; Yaoyao Zhou; Zhisong Li; Qian Bai
Journal:  Front Cell Dev Biol       Date:  2022-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.